KLI
HIV

Kelman-Lazarov Inc’s CALYPTE BIOMEDICAL CORP NEW HIV Stock Holding History

Kelman-Lazarov Inc’s Portfolio HIV Stock Details HIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-3,500
Closed – – 390
2016
Q3 		$0 Buy
+3,500
New – ﹤0.01% 399